bioMérieux S.A. (EPA: BIM)
France
· Delayed Price · Currency is EUR
102.20
+0.90 (0.89%)
Dec 20, 2024, 5:35 PM CET
bioMérieux Revenue
bioMérieux had revenue of 1.90B EUR in the half year ending June 30, 2024, with 14.71% growth. This brings the company's revenue in the last twelve months to 3.81B, up 2.85% year-over-year. In the year 2023, bioMérieux had annual revenue of 3.67B with 2.39% growth.
Revenue (ttm)
3.81B
Revenue Growth
+2.85%
P/S Ratio
3.17
Revenue / Employee
277.93K
Employees
13,982
Market Cap
12.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.67B | 85.60M | 2.39% |
Dec 31, 2022 | 3.59B | 212.90M | 6.31% |
Dec 31, 2021 | 3.38B | 258.00M | 8.27% |
Dec 31, 2020 | 3.12B | 443.40M | 16.58% |
Dec 31, 2019 | 2.67B | 253.50M | 10.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
Eurofins Scientific SE | 6.72B |
Ipsen S.A. | 3.44B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |
Vetoquinol SA | 537.47M |
bioMérieux News
- 3 months ago - bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux: Pioneering In Vitro Diagnostics - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha